Doximity, Inc. (DOCS) is a publicly traded Healthcare sector company. As of May 20, 2026, DOCS trades at $19.65 with a market cap of $3.62B and a P/E ratio of 15.59. DOCS moved +3.30% today. Year to date, DOCS is -56.53%; over the trailing twelve months it is -62.53%. Its 52-week range spans $17.15 to $85.21. Analyst consensus is buy with an average price target of $26.78. Rallies surfaces DOCS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Doximity Guides 4% FY27 Growth Despite Rapid AI Adoption, Shares Oversold: Doximity reported FY26 revenue growth with margin compression and guided FY27 revenue up just 4% with EBITDA margins pressured by ramped AI investments, despite rapid adoption of its clinical AI tools. Shares tumbled 25.7% over four weeks, becoming technically oversold as analysts raise earnings estimates.
| Metric | Value |
|---|---|
| Price | $19.65 |
| Market Cap | $3.62B |
| P/E Ratio | 15.59 |
| EPS | $1.27 |
| Dividend Yield | 0.00% |
| 52-Week High | $85.21 |
| 52-Week Low | $17.15 |
| Volume | 3.63M |
| Avg Volume | 0 |
| Revenue (TTM) | $637.78M |
| Net Income | $239.40M |
| Gross Margin | 89.75% |
21 analysts cover DOCS: 0 strong buy, 9 buy, 12 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $26.78.